Addressing the unmet needs in T2DM management

Addressing the unmet needs in T2DM management

Endocrinology
A badge with ribbon in color black 1 point | An analog clock in color black 20 minutes | A black calendar with white triangle in center that has a black exclamation point in the middle 18 Dec 2022 

Overview

The increasing global burden of type 2 diabetes (T2DM) is of considerable concern at the individual patient level as well as public health level. The goal of this learning activity is to provide doctors with a concise review of the current unmet needs in T2DM management, and how fixed-ratio combination (FRC) of insulin and glucagon like peptide-1 receptor agonist (GLP-1 RA) can potentially address these unmet needs. Upon completing this module, participants will have a better understanding of the following aspects:

• Patterns of insulin use in Malaysia

• Unmet needs in T2DM management

• Benefits of FRC therapy

• Switching from basal insulin to FRC therapy


CPD Reviewer:  

Dr Chan Siew Pheng

Honorary Professor

MBBS (Mal), FRCP (Edinburgh), AM (Mal)

Consultant Endocrinologist


Who should participate:

Doctors


NOTE :

Please read thoroughly & understand the module before attempting the assessment questions.


Terms & Conditions:

Participants must obtain a minimum score of 8/10 (80%) to be awarded 1 point.

MIMS Education and MIMS Medica shall not be responsible or liable for the outcome of your CPD points


The modules/articles are best viewed with:

Google Chrome, Firefox, Internet Explorer, Safari or any other W3C standards-compliant browser may be required to view the modules.


Supported by:


SANOFI_logo.jpg